PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
Items 501–596 of 596
Zhu, X.-B., Zou, Y., Jia, L., Ye, X., Zou, Y., Tu, J., Li, J., Yu, R., Yang, S., & Huang, P. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1164274 · Cited by 6
“TNF receptor-associated protein-1 (TRAP1), a member of the mitochondria-specific Hsp90 family, is located in the mitochondrial matrix, mitochondrial endometrium, and the intermembrane space (Cechetto and Gupta, 2000; Pridgeon et al., 2007).”
BackgroundTran, T. T. T., Tran, K. V., Nguyen, T. D., Pham, N. T. T., & Nguyen, T. H. (2025) · World Journal of Nephrology · doi:10.5527/wjn.v14.i3.107571 · Cited by 3
Un peu de Rose dans la maladie de Parkinson
Berthier, A. (2008) · médecine/sciences · doi:10.1051/medsci/2008242118 · Cited by 3
“permet de mieux comprendre la fonction de PINK1 [10].”
BackgroundUnveiling defects of secretion mechanisms in Parkinson’s disease
Filippini, F., & Galli, T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107603 · Cited by 5
Peptide Activator Stabilizes DJ-1 Structure and Enhances Its Activity
Shih, J.-Y., & Hsu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011075 · Cited by 3
“Both Parkin and PINK1 exhibit neuroprotective activity against oxidative stress [12,13].”
BackgroundLaquatra, C., Magro, A., Guarra, F., Lambrughi, M., Ferrone, L., Fracasso, G., Bacchin, M., Spina, M. L., Moroni, E., Papaleo, E., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07467-6 · Cited by 4
Strangers in strange lands: mitochondrial proteins found at extra-mitochondrial locations
Scanlon, D. P., & Salter, M. W. (2019) · Biochemical Journal · doi:10.1042/bcj20180473 · Cited by 4
PINK1 (PARK6) and Parkinson's Disease
Valente, E. M., & Ferraris, A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00005-2 · Cited by 4
Im, C., Zheng, Y. H., Kim, S. H., Huang, T.-Q., Cho, D., & Seo, J. (2013) · Interdisciplinary Bio Central · doi:10.4051/ibc.2013.5.4.0009 · Cited by 3
Etiology and pathogenesis of Parkinson’s disease: role of mitochondrial pathology
Brini, M., Ottolini, & Calí, T. (2013) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28413 · Cited by 6
“10 PINK1 knockout mice showed reduction mainly in complex I activity but also in complexes II and III.”
King, L., & Plun‐Favreau, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00005-5 · Cited by 7
Genetics of Parkinson's Disease—An Overview
Klein, C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00002-7 · Cited by 3
Zebrafish as a model of Parkinson's disease
Sallinen, V. J. (2009) · Helda - University of Helsinki Institutional Repository · Cited by 5
PINK1 Regulates Dopamine and Lipids at Mitochondria to Maintain Synapses and Neuronal FunctionPreprint
Bus, C., Geisler, S., Feldkaemper, M. P., Flores‐Romero, H., Schaedler, A., Zittlau, K. I., Zarani, M., Uysal, B., Casadei, N., Fallier‐Becker, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/814343 · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
Joshi, A., Dai, L., Maisiak, M., Lee, S., Lopez, E. F., Ito, T., & Neckers, L. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0194 · Cited by 5
“Given that oxidative stress is a frequently observed phenotype associated with TRAP1 dysfunction or loss (5, 25, 26, 41, 42), we hypothesized that redirection of Glc to the PPP to generate reducing power may be a general consequence in cells lacking the TRAP1 protein (5, 25–28).”
PTEN-induced kinase1 (PINK1): More than just mitochondrial quality control
Shamsi, T. N., Payoe, R., Mohammad, T., & James, M. N. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91287-7.00004-1 · Cited by 3
Chauhan, P., Pandey, P., Khan, F., & Maqsood, R. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303249690231006114308 · Cited by 2
Bases moléculaires de la maladie de Parkinson
Lesage, S., & Brice, A. (2010) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(10)51090-x · Cited by 2
Mitochondrial Biology in Parkinson's Disease
Lee, Y. (2009) · Interdisciplinary Bio Central · doi:10.4051/ibce.2009.2.0011 · Cited by 2
“According to previous studies on PINK1, PINK1 kinase activity is upregulated by oxidative stress (Pridgeon et al., 2007).”
BackgroundUse of Caenorhabditis elegans to Model Human Movement Disorders
Caldwell, G. A., & Caldwell, K. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00006-8 · Cited by 2
Долгачева, Л. П., Fedotova, E. I., Abramov, A. Y., & Berezhnov, A. V. (2017) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.7868/s0233475517050012 · Cited by 1
Lee, Y. M., Hu, D., & Liou, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-0522-2_5 · Cited by 1
The Internal Ribosome Entry Site in Circular RNAs
Fernandes, Q., Yoosuf, Z. S. K. M., Mestiri, S., Assami, L., Makni‐Maalej, K., Shahab Uddin, M. S., Merhi, M., & Dermime, S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-981-96-9428-0_9 · Cited by 1
Mechanisms Associated with PINK1 Mutations in Parkinson's Disease
Dan, H., Huang, X., Liu, Z., Wei, B., & Musa, M. B. (2025) · F1000Research · doi:10.12688/f1000research.170090.1 · Cited by 1
Parkinson’s Disease: Insights from the Laboratory and Clinical Therapeutics
Zhou, J.-Y., Yu, Y., Zhu, X.-L., Ng, C.-P., Lü, G., & Poo, W.-S. (2012) · InTech eBooks · doi:10.5772/33092 · Cited by 1
“Kinase assays suggested that multiple PINK1 mutants associated with autosomal recessive PD have reduced kinase activity (60, 183-185).”
BackgroundLow thymine content in PINK1 mRNAs and insights into Parkinson’s disease
Anandagopu, P., Banu, S., & Li, J. (2010) · Bioinformation · doi:10.6026/97320630004452 · Cited by 1
HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions
Powers, M. V., & Workman, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-8526-0_7 · Cited by 1
Mutual Neurotoxic Mechanisms Controlling Manganism and Parkisonism
Roth, J. A. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00221 · Cited by 1
The use of cell-free systems to characterize parkinson's disease-related gene products
Rochet, J., & Schieler, J. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00043-9 · Cited by 1
Zeviani, M., & Ghezzi, D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.7519969.8027061 · Cited by 1
Zhang, X., Liu, X., Qiao, Y., Rabata, A., Liu, N., Yao, C., Parimon, T., Chen, D., Chen, P., Stripp, B. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.662456 · Cited by 1
Zebrafish as a Model for the Study of Parkinson’s Disease
Xi, Y. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4585
“Over-expression of PINK1 in cell culture seems to protect neurons against mitochondrial dysfunction and apoptosis induced by stress (Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundMolecular Genetics of Parkinsonism
Lesage, S., & Brice, A. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0022386.pub2
Olanow, C. W., & Lang, A. E. (2011) · Wiley eBooks · doi:10.1002/9781444397970.ch39 · Cited by 1
Parkinson disease: identifying different players sharing a common principle
Farooqı, A. A., Arshad, S., Fayyaz, S., Abbas, S., & Bhatti, S. (2011) · Research in Biotechnology
Genetic Basis of Monogenic Forms of Parkinson Disease
Brockmann, K., & Gasser, T. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022397
“Moreover, they found out that the ability of PINK1 to enhance TRAP1 phosphorylation leading to cell survival is affected by PD-associated PINK1 mutations (Pridgeon et al., 2007).”
BackgroundSilva, R. D. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2014.tde-31102014-105854
Emerging Concepts Linking Mitochondrial Stress Signalling and Parkinson's Disease
Ana, C., Miguel, L., & Loh, S. H. Y. (2012) · InTech eBooks · doi:10.5772/34689 · Cited by 1
“It participates in molecular quality control through interactions with high-temperature-requirement protein A2 (HtrA2) and possibly TNF receptor–associated protein 1 (TRAP1) and at the organellar level via its activity in a signalling pathway involving parkin and mitophagy.”
The impact of mitochondria on preimplantation development in the rhesus macaque
Gibson, T. C. (2010) · Human Biology
Mutations in Nuclear Genes That Affect Mitochondrial Function in Parkinson’s Disease
Charlesworth, G., & Wood, N. W. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_3
Mitochondria in Parkinson's Disease
Arena, G., & Valente, E. M. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch16
Pink1 Rescues Gal4-Induced Developmental Defects in the Drosophila Eye
Todd, A. M., & Staveley, B. E. (2015) · Advances in Parkinson s Disease · doi:10.4236/apd.2015.43006
“For example, the phosphorylation of TRAP1 (Hsp75) by Pink1 has been shown to protect against oxidative stress and prevent cytochrome c release [25].”
BackgroundDo mitochondria provide a common link between diabetes and Parkinson's disease?
Timmons, J., Schéele, C., & Wahlestedt, C. (2007) · Practical Diabetes · doi:10.1002/pdi.1136
Basi molecolari del morbo di Parkinson
Lesage, S., & Brice, A. (2010) · EMC - Neurologia · doi:10.1016/s1634-7072(10)70497-9
The role of PTEN in cardioprotection against ischaemia-reperfusion injury
Siddall, H. K. (2009) · UCL Discovery (University College London) · Cited by 1
Recessive Parkinsonism, Mitochondria and Translational Regulation
Blackinton, J. G. (2008) · Figshare
Systemic and Cell-Type Specific Profiling of Molecular Changes in Parkinson`s Disease
Lee, Y. (2012) · Interdisciplinary Bio Central · doi:10.4051/ibc.2012.4.3.0006
Functional Genomics Studies of PINK1
Schéele, C. (2007) · Figshare
Mechanism of action of autosomal recessive juvenile parkinsonism gene mutations
Sandebring, A. (2010) · Figshare
Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie
Schlehe, J. S. (2008)
Folding, function and subcellular localization of parkin
Schlehe, J. S. (2008) · doi:10.5282/edoc.9266
Understanding the Role of Sirtuin 3 in a Cell Model of Parkinson's Disease
Lizal, K. E. (2013) · TSpace (University of Toronto)
Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration
Chaput, D. (2015) · Digital Commons - University of South Florida (University of South Florida)
Stratford, E. W. (2014) · Annual Research & Review in Biology · doi:10.9734/arrb/2014/8998
“Although the function of TRAP1 has not been nearly as well studied as the function of PML, TRAP1 has an anti-apoptotic function [14,15,16,17,18,28], and silencing of TRAP1 results in induction of apoptosis [16].”
BackgroundPINK1 as a Sensor for Mitochondrial Function
Steer, E. K., Dail, M. K., & Chu, C. T. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch11
Function study advances of Parkinson¢s disease related genes
Wang, X.-M., Wang, D., & Xiao-Yan, W. A. N. G. (2010) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.00779
The Role of Parkin and PINK1 in Mitochondrial Quality Control
Tang, M. Y. H., & Durcan, T. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801032-7.00018-6 · Cited by 2
Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease
Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23
9.7 Neuroprotective Strategies in Parkinson’s Disease
Olanow, C. W. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0035
Yeast Cells as a Discovery Platform for Parkinson's Disease and other Protein Misfolding Diseases
Allendoerfer, K. L., Su, L. J., & Lindquist, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00038-5 · Cited by 1
Misiak, M., & Arnold, S. (2010) · RWTH Publications (RWTH Aachen)
Butler, E. K. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3186
Protein Oxidation, Quality-Control Mechanisms and Parkinson’s Disease
Hernández-Franco, P., Anandhan, A., & Franco, R. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00277 · Cited by 1
Regulation of mitochondrial and nonmitochondrial protein turnover by the PINK1-Parkin pathway
Vincow, E. S. (2013) · ResearchWorks at the University of Washington (University of Washington)
Studying the Prevalence and Genetic Contributions to Parkinsonism in Pakistan
Khan, S. (2016) · Griffith Research Online · doi:10.25904/1912/2713
Understanding the Role of Rhomboid Proteases and Their Substrates in Parkinson's Disease
Morrison, M. A. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3kd1qt41
Dhanushkodi, N. R., & Haque, M. E. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_2
Molecular Mechanisms Underlying the Role of Mitophagy in Neurodegeneration
Ahlawat, A., Kaira, M., Walia, V., & Garg, M. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch003
Role of Mitochondrial Dynamics and Autophagy in Removal of Helix-Distorting Mitochondrial DNA Damage
Bess, A. S. (2012) · DukeSpace (Duke University)
Chase, B. A., & Markopoulou, K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00502-5
Molecular Genetics of Parkinsonism
Lesage, S., & Brice, A. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022386
Westrate, L. M., & MacKeigan, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_206
Westrate, L. M., & MacKeigan, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_206
MICROTUBULE DYNAMICS IN OXIDATIVELY-STRESSED NEURONAL CELLS
Patel, V. P. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Chapter 13. Intracellular Signaling Pathways in Parkinson's Disease
Sánchez-Contreras, M., & Cardozo‐Pelaez, F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733434-00247
The genetic basis of neurodegenerative disorders: Implications in Alzheimer's disease
Jilani, M. G., Hoque, M., Tabrez, S. S. M., & Ali, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00002-1 · Cited by 1
Matassa, D. S., Criscuolo, D., Avolio, R., Agliarulo, I., Sarnataro, D., Pacelli, C., Scrima, R., Colamatteo, A., Matarese, G., Capitanio, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26553257
Matassa, D. S., Criscuolo, D., Avolio, R., Agliarulo, I., Sarnataro, D., Pacelli, C., Scrima, R., Colamatteo, A., Matarese, G., Capitanio, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26553254
Khalil, B. (2016) · theses.fr (ABES) · doi:10.70675/4446111fz4182z4737zae76z7f117887a893
Contrôle de la mitophagie dans la maladie de Parkinson : Dialogue fonctionnel entre XBP1 et PINK1
Manaa, W. E. (2019) · theses.fr (ABES) · doi:10.70675/3428bd72z68cdz42f6za6d1z35ce71263711
Anomalies de la mitophagie au cours de la maturation érythroïde dans la drépanocytose
Martino, S. (2020) · theses.fr (ABES) · doi:10.70675/a131d6c1z5236z45e9z93e3zec879bb0d4ff
Mathieu, C. (2021) · theses.fr (ABES) · doi:10.70675/22a753dcze788z44dfz8a6az8a41b201d605
Mechanisms Associated with PINK1 Variants in Parkinson's Disease
Dan, H., Huang, X., Liu, Z., Wei, B., & Musa, M. B. (2026) · F1000Research · doi:10.12688/f1000research.170090.2
Mercer, T. J., Dániel, B., Fredrickson, C., Le, D., Lee, S., Kulkarni, V. V., Hou, X., Fiesel, F. C., Ngu, H., Jung, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.719390 · Cited by 1
Ambrosini, G., Pozza, E. D., Cristanini, I., Vinco, S., Cappellozza, E., Cisterna, B., Laquatra, C., Rasola, A., Bottani, E., & Dando, I. (2026) · Cancer Drug Resistance · doi:10.20517/cdr.2025.229
Trafficking of protein kinases to mitochondria: Implications for ischemic stroke
Pandya, C. D., Kunjadiya, A. P., Dalwadi, P., Singh, R., Khan, S. N., Pennypacker, K. R., Fraser, J. F., Stowe, A. M., & Sullivan, P. G. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113176
Germline mitophagy selectively eliminates deleterious mitochondrial DNA across generationsPreprint
Ahier, A., Onraet, T., Campbell, D., Townsend, B., Bezawork‐Geleta, A., Dowlath, S., Hahn, A., Lee, R. S. Y., Dai, C.-Y., Gaudin, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.24.734151
Ramos, A. B. M. F. M., & Morais, V. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136073
“It has been shown that PINK1 associates with TRAP1 in the mitochondria and phosphorylates this protein, protecting against oxidative stress and promoting cell survival [28].”
Arias-Carrión, Ó., Guerra‐Crespo, M., Soto-Rojas, L. O., Valle, Y., Ortega‐Robles, E., & Ortuño‐Sahagún, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1886917 · Cited by 2
“TRAP1, a mitochondrial chaperone, is one such substrate; its phosphorylation enhances resistance to oxidative stress (Pridgeon et al., 2007).”
Khan, A., Jawaid, T., Rehman, Z. U., Alshammari, M. K., Bakht, M. A., Shakeel, F., Zawiah, M., & Imran, M. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116078
Deguil, J. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.